Citadel Advisors »

Trinity Biotech shares owned by Citadel Advisors

Quarter-by-quarter ownership of Trinity Biotech (TRIB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Trinity Biotech

Tip: Access up to 7 years of quarterly data

All positions including Trinity Biotech held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trinity Biotech by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $16k 14k 1.10
2024-06-30 $34k 16k 2.07

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Trinity Biotech

Perceptive Advisors
Hunter Associates
Renaissance Technologies
Whitefort Capital Management
Acadian Asset Management
Hrt Financial
Moss Adams Wealth Advisors
Cambridge Investment Research Advisors
Becker Capital Management
Virtu Financial
Citadel Advisors
Susquehanna International
Integrys Wealth Advisors
Morgan Stanley
SJS Investment Consulting

View all funds holding Trinity Biotech